SMH vs XBI

VanEck Semiconductor ETF vs SPDR S&P Biotech ETF

Quick take
  • XBI pays a higher dividend yield (0.36%).

Side-by-side metrics

MetricSMHXBI
Expense ratio
Annual fee. Lower is better.
0.35%0.35%
Dividend yield
Trailing 12-month yield.
0.17%0.36%
AUM
Assets under management — bigger funds are typically more liquid.
$77.20B$10.73B
YTD return
64.66%33.79%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
1.981.10
P/E ratio
39.75
Last price
$613.98$164.01
Inception
Issuer
VanEckState Street

SMH top holdings

Top holdings · SMH
NVDANVIDIA Corp17.75%
TSMTaiwan Semiconductor Manufacturing Co Ltd ADR9.19%
MUMicron Technology Inc5.84%
AMATApplied Materials Inc5.73%
AMDAdvanced Micro Devices Inc5.43%
AVGOBroadcom Inc5.41%
KLACKLA Corp5.34%
LRCXLam Research Corp5.23%
INTCIntel Corp5.04%
ASMLASML Holding NV ADR4.95%
Sector breakdown · SMH
Technology100.0%

XBI top holdings

Top holdings · XBI
APGEApogee Therapeutics Inc1.49%
MRNAModerna Inc1.41%
TWSTTwist Bioscience Corp1.41%
ORKAOruka Therapeutics Inc1.38%
KYMRKymera Therapeutics Inc Ordinary Shares1.36%
VKTXViking Therapeutics Inc1.30%
PRAXPraxis Precision Medicines Inc Ordinary Shares1.29%
ERASErasca Inc1.27%
RVMDRevolution Medicines Inc Ordinary Shares1.20%
RYTMRhythm Pharmaceuticals Inc1.20%
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%

About SMH

SMH (VanEck Semiconductor ETF) is 25 largest semiconductor companies. Managed by VanEck, the fund carries $77.2B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.17%. Its largest holding is NVIDIA Corp (NVDA), which represents 17.8% of the portfolio. Technology is the fund's largest sector exposure at 100.0%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.